| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2006P-0209
|
| Safety or Efficacy of Diastat (diazepam rectal gel), 5 mg/ml, 10mg/2 ml, 15 mg/3 ml and 20 mg/4 ml
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC4
|
|
|
|
|
| Submitter :
|
| Mr. Dave Lowe
|
| Date & Time:
|
| 06/27/2006 11:06:16
|
|
|
|
|
| Organization :
|
| Mr. Dave Lowe
|
|
|
|
|
| Category :
|
| Individual Consumer
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| I oppose the petition offering safety and efficacy, however raise an issue. Pfizer/Roeger's revised May 2005 label misbrands both flavors of Geodon. Geodon is both ziprasidone HCL and ziprasidone mesylate. Not safe for use, Geodon should be withdrawn, and any paper that left clinical trial data posted in live updates. ATTACHMENT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2006P-0209-EC4-Attach-1.PDF
|
|